Satsuma Pharmaceuticals Inc (STSA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

400 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 64080

Satsuma Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops novel therapeutic products for the acute treatment of migraine. Satsuma Pharmaceuticals serves customers in the State of California.

Data as of 2021-05-08 12:03:38 -0400
Market Cap160.485 Million Shares Outstanding31.529 Million Avg 30-day Volume113.818 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.64 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.79976 52-week High/Low36.1 / 3.5 Next Earnings Date2021-05-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from STSA instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 50 48 4.17% 17 (1.02%) 17 (1.06%) 0.0%
13F shares: 10.596 Million 9.829 Million 7.8% 7.172 Million 6.479 Million 10.7%
% Ownership 60.8185 56.4163 7.8% 41.1677 37.189 10.7%
New Positions: 12 15 -20.0% 5 10 -50.0%
Increased Positions 13 10 30.0% 4 3 33.33%
Closed Positions 10 20 -50.0% 5 11 -54.55%
Reduced Positions 15 15 0.0% 6 3 100.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding STSA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding STSA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
5,914,252 2021-04-01 2

KING THOMAS BRAXTON

  • Director
0 2020-12-03 2

O'NEIL THOMAS P. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-12-03 7

KOLLINS JOHN A PRESIDENT AND CEO

  • Officer
  • Director
0 2020-12-03 1

SANDOVAL ELISABETH

  • Director
0 2020-12-03 2

TAKANASHI KEN

  • Director
1,561,719 2020-12-03 2

RIEBE MICHAEL T

  • Director
0 2020-12-03 2

SHAH RAJEEV M.

  • Director
  • 10% Owner
0 2020-12-03 2

LUKATCH HEATH

  • Director
0 2020-12-03 3

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • Director
  • 10% Owner
0 2020-12-03 1

ALBRECHT DETLEF CHIEF MEDICAL OFFICER

  • Officer
0 2020-12-03 5

SOLOWAY THOMAS P

  • Director
0 2020-12-03 3

HADLEY HARBOR MASTER INVESTORS (CAYMAN) II L.P.

  • 10% Owner
1,105,154 2019-09-17 0

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
1,885,939 2019-09-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

RA CAPITAL MANAGEMENT, L.P. - Director - > 10% Owner see footnote

RA CAPITAL HEALTHCARE FUND LP - > 10% Owner see footnote

KOLCHINSKY PETER - > 10% Owner see footnote

SHAH RAJEEV M. - > 10% Owner see footnote

2021-04-05 16:34:04 -0400 2021-04-01 J 566,011 $5.91 a 566,011 indirect -1.0453 -6.2718 0.0 1 -10.453 5

RA CAPITAL MANAGEMENT, L.P. - Director - > 10% Owner see footnote

RA CAPITAL HEALTHCARE FUND LP - > 10% Owner see footnote

KOLCHINSKY PETER - > 10% Owner see footnote

SHAH RAJEEV M. - > 10% Owner see footnote

2021-04-05 16:34:04 -0400 2021-04-01 J 192,387 $5.91 a 5,348,241 indirect -1.0453 -6.2718 0.0 1 -10.453 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 22:15:04 UTC -0.3884 0.4384 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 21:45:02 UTC -0.3884 0.4384 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 21:15:02 UTC -0.3884 0.4384 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 20:45:03 UTC -0.3884 0.4384 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 20:15:03 UTC -0.3884 0.4384 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 19:45:03 UTC -0.3555 0.4055 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 19:15:03 UTC -0.3555 0.4055 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 18:45:03 UTC -0.3555 0.4055 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 18:15:03 UTC -0.3555 0.4055 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 17:45:02 UTC -0.3555 0.4055 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 17:15:03 UTC -0.3555 0.4055 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 16:45:03 UTC -0.384 0.434 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 16:15:03 UTC -0.384 0.434 300000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 15:45:03 UTC -0.384 0.434 7000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 15:15:03 UTC -0.384 0.434 7000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 14:45:04 UTC -0.3064 0.3564 8000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 14:15:04 UTC -0.3064 0.3564 8000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 13:45:04 UTC -0.3064 0.3564 8000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 13:15:03 UTC -0.3064 0.3564 8000
SATSUMA PHARMACEUTICALS INC STSA 2021-05-10 12:45:02 UTC -0.3064 0.3564 10000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund STSA -3.0 shares, $-64.56 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund STSA -4.0 shares, $-86.08 2020-03-31 N-PORT

Elevate your investments